Favipiravir in Therapy of Viral Infections

Favipiravir (FPV) is a novel antiviral drug acting as a competitive inhibitor of RNA-dependent RNA polymerase (RdRp), preventing viral transcription and replication. FPV was approved in Japan in 2014 for therapy of influenza unresponsive to standard antiviral therapies. FPV was also used in the ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Łagocka, Ryta, Dziedziejko, Violetta, Kłos, Patrycja, Pawlik, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828521/
https://www.ncbi.nlm.nih.gov/pubmed/33451007
http://dx.doi.org/10.3390/jcm10020273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828521/
https://www.ncbi.nlm.nih.gov/pubmed/33451007
http://dx.doi.org/10.3390/jcm10020273

Ejemplares similares